10:40 AM EST - Resinco Capital Partners Inc. : Has entered into a definitive agreement to acquire the remaining 51% of ReFormation Pharmaceuticals Corp, a medical cannabis company developing innovative, first-in-class therapies to repair vital organs and stem cells by combining cannabinoids and an endogenous trigger of repair. Resinco previously acquired 49% of ReFormation's outstanding shares on October 23, 2018. Resinco Capital Partners Inc.
shares RIN.CC are trading down $0.055 at $0.19.
